Peptide P11 suppresses the growth of human thyroid carcinoma by inhibiting the PI3K/AKT/mTOR signaling pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peptide P11 suppresses the growth of human thyroid carcinoma by inhibiting the PI3K/AKT/mTOR signaling pathway
Authors
Keywords
-
Journal
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-04-27
DOI
10.1007/s11033-019-04698-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways
- (2018) Dong-Dong Wu et al. BMC CANCER
- MAFb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma
- (2018) Ya-Wei Qiang et al. BMC CANCER
- The mTOR Kinase Inhibitor CZ415 Inhibits Human Papillary Thyroid Carcinoma Cell Growth
- (2018) Xiaobin Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The effect of tubeimoside-1 on the proliferation, metastasis and apoptosis of oral squamous cell carcinoma in vitro
- (2018) Tingting Wu et al. OncoTargets and Therapy
- Metastasis: Lymphatic detours for cancer
- (2017) Ayuko Hoshino et al. NATURE
- Morin Inhibits Proliferation of SW480 Colorectal Cancer Cells by Inducing Apoptosis Mediated by Reactive Oxygen Species Formation and Uncoupling of Warburg Effect
- (2017) Thomas Sithara et al. Frontiers in Pharmacology
- Hydrogen sulfide ameliorates chronic renal failure in rats by inhibiting apoptosis and inflammation through ROS/MAPK and NF-κB signaling pathways
- (2017) Dongdong Wu et al. Scientific Reports
- Hydrogen sulfide promotes angiogenesis by downregulating miR-640 via the VEGFR2/mTOR pathway
- (2016) Yu Zhou et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma
- (2016) Benjamin M. Ellingson et al. CANCER
- Reversal of Beta-Amyloid-Induced Neurotoxicity in PC12 Cells by Curcumin, the Important Role of ROS-Mediated Signaling and ERK Pathway
- (2016) Cun-dong Fan et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status
- (2015) Martina Broecker-Preuss et al. BMC CANCER
- Lenvatinib and radioiodine-refractory thyroid cancers
- (2015) Lara Dunn et al. Nature Reviews Endocrinology
- Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
- (2015) Andras Perl Nature Reviews Rheumatology
- Hydrogen sulfide in cancer: Friend or foe?
- (2015) Dongdong Wu et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Peptide-based cancer therapy: Opportunity and challenge
- (2014) Dongdong Wu et al. CANCER LETTERS
- CDK4/6 and IGF1 Receptor Inhibitors Synergize to Suppress the Growth of p16INK4A-Deficient Pancreatic Cancers
- (2014) A. M. Heilmann et al. CANCER RESEARCH
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- Pax-8–PPAR-γ fusion protein in thyroid carcinoma
- (2014) Priyadarshini Raman et al. Nature Reviews Endocrinology
- Development of PI3K inhibitors: lessons learned from early clinical trials
- (2013) Jordi Rodon et al. Nature Reviews Clinical Oncology
- Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene
- (2013) YOUNG SO et al. ONCOLOGY REPORTS
- Tumor angiogenesis and lymphangiogenesis: Tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms
- (2012) Fausto Gueths Gomes et al. LIFE SCIENCES
- Evaluation of 111In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability
- (2012) Jiyun Shi et al. Theranostics
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine
- (2011) Lucia Kucerova et al. CANCER LETTERS
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Anti-tumor effects of a novel chimeric peptide on S180 and H22 xenografts bearing nude mice
- (2010) Dongdong Wu et al. PEPTIDES
- Tumor-Associated Angiogenesis and Lymphangiogenesis Correlate With Progression of Intrahepatic Cholangiocarcinoma
- (2009) Armin Thelen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More